Long-term safety study of TLL-018 for rheumatoid arthritis patients
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study offers continued access to TLL-018 for people with rheumatoid arthritis who completed the earlier study (TLL-018-301). It checks long-term safety and helps researchers understand if the medicine remains effective over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have finished the TLL-018-301 study within the last 3 months
- You need to be between 18 and 75 years old
- You must not be pregnant, breastfeeding, or planning to donate eggs or sperm during the study
- You and your partner must use effective birth control for at least 90 days after the last dose
- You cannot have had a severe allergic reaction to the study drug, or conditions like shingles, heart problems, blood clots, or certain immune cell cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called SR-878 for people with rheumatoid arthritis. It aims to see if the drug is safe and tolerable. You may join if you are between 18 and 60, have RA for at least 3 months, and take a stable dose of methotrexate.
This trial tests a new experimental antibody called GNC-038 for people with moderate to severe rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if targeting specific immune cells can reduce inflammation and improve symptoms.
This trial studies an add-on treatment approach for rheumatoid arthritis (RA) in adults whose symptoms did not improve with standard “first-line” medicines. It may help people who still have active RA after trying certain disease-modifying drugs.
This study tests a new drug, LFD-200, in healthy adults and in adults with moderate to severe rheumatoid arthritis who have active symptoms despite methotrexate. The goal is to see if it's safe and how it affects the disease.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This trial tests whether combining Telitacicept and Tofacitinib can help people with rheumatoid arthritis that hasn't improved with at least two other advanced treatments. The goal is to see if these drugs work better together for hard-to-treat cases.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.